Search Results 2101-2110 of 18397 for Topical

  1. Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma - Mayo Clinic

    About this study. This open-label, randomized, 2-arm, multicenter, phase 3 study has the primary objective of comparing the modified progression-free ...

  2. ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent - Mayo Clinic

    The primary objective of this trial is to evaluate the safety and effectiveness of the Boston Scientific Corporation (BSC) ELUVIA Drug-Eluting Vascular Stent ...

  3. Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety tolerability, PK, preliminary antitumor activity, and effect of biomarkers of XL092 ...

  4. A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

    The primary objective of this study is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal ...

  6. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...

  7. A Study Of The Performance, Effectiveness And Safety Of A Vibrating Capsule Device In Aiding Constipated Individuals - Mayo Clinic

    About this study. This is a study intended to evaluate the effectiveness and safety of the vibrating capsule device versus a sham non-vibrating capsule on ...

  8. Mayo Clinic launches $3 billion campaign to set new world standard in care

    Join the fight against cancer! ... Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated. Give Now.

  9. Study Of Targeted Therapy Vs. Chemotherapy In Patients With Thyroid Cancer - Mayo Clinic

    The purpose of this study is to compare progression-free survival (PFS) in patients with BRAF V600Em differentiated thyroid cancer who progressed on frontline ...

  10. Open-Label Tolvaptan Study in Subjects With ADPKD - Mayo Clinic

    To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from baseline (from trial 156-04-251) in total kidney volume (TKV) and renal ...